[Retracted] Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling

Table 2

Clinical and histopathological characteristics according to 14-3-3σ status in 65 extrahepatic cholangiocarcinomas.

	14-3-3σ expression			value
	Total ()	Negative ()	Positive ()
Gender (%)
Male	37 (56.9)	5 (55.6)	32 (57.1)	NS
Female	28 (43.1)	4 (34.4)	24 (42.9)
Age (%)
≥65 years	22 (33.8)	4 (34.4)	18 (32.1)	NS
<65 years	43 (66.2)	5 (55.6)	38 (67.9)
Tumor size (%)
>2.5 cm	45 (69.2)	3 (33.3)	42 (75.0)	0.020
≤2.5 cm	20 (30.8)	6 (66.7)	14 (25.0)
Pathologic differentiation (%)
Well	30 (46.2)	2 (22.2)	28 (50.0)	NS
Moderate	29 (44.6)	4 (44.4)	25 (44.6)
Poor	6 (9.2)	3 (33.4)	3 (5.4)
Lymphatic permeation (%)
No	27 (41.5)	7 (77.8)	20 (35.7)	0.027
Yes	38 (58.5)	2 (22.2)	36 (64.3)
Tumor stage (%)
I+II	25 (38.5)	8 (66.7)	17 (32.1)	0.001
III+IV	40 (61.5)	1 (33.3)	39 (67.9)